Syndevrx
Cambridge
About Syndevrx
Syndevrx is a biotech company that specializes in the development of treatments for cancers sensitive to metabolic hormones. Its drugs focus to treat the tumor directly and improve the underlying metabolic hormone dysfunction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $44.1M
- Last round: Series Unknown (Oct 2024)
- Website: syndevrx.com
- Phone: 617-401-3110
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/syndevrx-48072 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.